Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0N2DK
|
|||
Drug Name |
PMID29671355-Compound-44
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A
|
|||
Structure |
Download2D MOL |
|||
Formula |
C20H25F3N4O5
|
|||
Canonical SMILES |
C1CC(=O)NC1C(=O)NC(CCCCCC(=O)NO)C(=O)NC2=CC=CC(=C2)C(F)(F)F
|
|||
InChI |
1S/C20H25F3N4O5/c21-20(22,23)12-5-4-6-13(11-12)24-18(30)14(7-2-1-3-8-17(29)27-32)26-19(31)15-9-10-16(28)25-15/h4-6,11,14-15,32H,1-3,7-10H2,(H,24,30)(H,25,28)(H,26,31)(H,27,29)/t14-,15+/m0/s1
|
|||
InChIKey |
XVGBJXUAVWXLJX-LSDHHAIUSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | HDAC inhibitors: a 2013-2017 patent survey.Expert Opin Ther Pat. 2018 Apr 19:1-17. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.